STOCK TITAN

Tandem Diabetes Care Announces Upcoming Conference Presentation

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Tandem Diabetes Care (NASDAQ: TNDM) will present a company update at the UBS Genomics 2.0 and Medtech Innovations Summit on August 12, 2021, at 2:00 PM ET. The presentation will be available via a live webcast, with an archived recording accessible for 30 days thereafter. The link can be found on the Investor Center section of Tandem's website. Tandem focuses on improving the lives of people with diabetes through innovative medical devices, including their flagship product, the t:slim X2 insulin pump, which supports remote software updates and features integrated glucose monitoring.

Positive
  • None.
Negative
  • None.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the UBS Genomics 2.0 and Medtech Innovations Summit on Thursday, August 12, 2021 at 2:00pm Eastern Time (11:00am Pacific Time).

The Company update presentation will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem’s flagship product, the t:slim X2™ insulin pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring. Tandem is based in San Diego, California.

Tandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2, and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.

FAQ

What date will Tandem Diabetes Care present at the UBS Summit?

Tandem Diabetes Care will present at the UBS Genomics 2.0 and Medtech Innovations Summit on August 12, 2021.

How can I watch the Tandem Diabetes Care presentation?

The Tandem Diabetes Care presentation will be available via a live webcast on their Investor Center website.

What is Tandem Diabetes Care's flagship product?

Tandem's flagship product is the t:slim X2 insulin pump, which features remote software updates and integrated continuous glucose monitoring.

Where is Tandem Diabetes Care headquartered?

Tandem Diabetes Care is headquartered in San Diego, California.

How long will the archived presentation be available?

The archived recording of the presentation will be available for 30 days after the event.

Tandem Diabetes Care, Inc.

NASDAQ:TNDM

TNDM Rankings

TNDM Latest News

TNDM Stock Data

2.22B
65.14M
0.77%
114.13%
11.24%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
San Diego